用于预测全关节置换术后90天再入院的Elixhauser合并症加权指数
本研究基于单中心2013年6月至2018年1月10022例初次单侧全关节置换(髋4535例、膝5487例),从电子病历提取31项Elixhauser合并症,随机分为推导组(80%)与验证组(20%),构建90天再入院预测模型并转化为加权评分系统;观察到497例(5.0%)90天再入院,加权评分模型AUC为0.653,与包含全部31项未加权参数的多变量模型AUC 0.665相比未明显损失预测区分度,评分0分者再入院风险为3%,评分≥8分者为27%。
要点
- 31项Elixhauser合并症中14项与90天再入院独立相关。
- 加权评分模型AUC为0.653,全参数多变量模型AUC为0.665。
- 评分0分者再入院风险3%,评分≥8分者再入院风险27%。
核心结论
- Elixhauser合并症评分已达到或超过现有风险计算器的预测区分度。
- 该评分单独使用尚不充分,但可作为患者合并症的有价值总结,值得纳入预测全关节置换术后90天再入院风险的更广泛模型。
研究设计与样本
- 研究纳入2013年6月至2018年1月单中心10022例初次单侧全关节置换,其中髋置换4535例、膝置换5487例。
- 通过结构化查询语言从电子病历提取Elixhauser合并症,随机分为推导组(80%)与验证组(20%),生成90天再入院预测模型并转化为基于各参数相对性能的加权评分系统。
- 证据等级为III级。
主要发现
- 研究期间观察到497例90天再入院(5.0%),31项Elixhauser合并症组中14项与再入院独立相关。
- 加权合并症评分AUC为0.653,包含全部31项未加权Elixhauser参数的多变量模型AUC为0.665。
- 再入院风险从评分0分者的3%到评分≥8分者的27%。
关键数值与推荐
- 31项Elixhauser合并症中14项与90天再入院独立相关。
- 加权评分模型AUC为0.653,全参数多变量模型AUC为0.665。
- 评分0分者90天再入院风险为3%,评分≥8分者为27%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evolving reimbursement models increasingly compel hospitals to assume costs for 90-day readmission after total joint arthroplasty. Although risk assessment tools exist, none currently reach the predictive performance required to accurately identify high-risk patients and modulate perioperative care accordingly. Although unlikely to perform adequately alone, the Elixhauser index is a set of 31 variables that may lend value in a broader model predicting 90-day readmission. METHODS: Elixhauser comorbidities were examined in 10,022 primary unilateral total joint replacements, of which 4535 were hip replacements and 5487 were knee replacements, all performed between June 2013 and January 2018 at a single tertiary referral center. Data were extracted from electronic medical records using structured query language. After randomizing to derivation (80%) and validation (20%) subgroups, predictive models for 90-day readmission were generated and transformed into a system of weights based on each parameter's relative performance. RESULTS: We observed 497 90-day readmissions (5.0%) during the study period, which demonstrated independent associations with 14 of the 31 Elixhauser comorbidity groups. A score created from the sum of each patient's weighted comorbidities did not lose substantial predictive discrimination (area under the curve: 0.653) compared to a comprehensive multivariable model containing all 31 unweighted Elixhauser parameters (area under the curve: 0.665). Readmission risk ranged from 3% for patients with a score of 0 to 27% for those with a score of 8 or higher. CONCLUSIONS: The Elixhauser comorbidity score already meets or exceeds the predictive discrimination of available risk calculators. Although insufficient by itself, this score represents a valuable summary of patient comorbidities and merits inclusion in any broader model predicting 90-day readmission risk after total joint arthroplasty. LEVEL OF EVIDENCE: III.
引用
- Goltz DE, Ryan SP, Howell CB, et al. A Weighted Index of Elixhauser Comorbidities for Predicting 90-day Readmission After Total Joint Arthroplasty. J Arthroplasty. 2019. PMID: 30765228. doi:10.1016/j.arth.2019.01.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。